Skip to main navigation Skip to search Skip to main content

Doubtful model utility in predicting high vancomycin minimum inhibitory concentration methicillin-resistant staphylococcus aureus bloodstream infection episodes

  • Sebastiaan J. Van Hal*
  • , Mark Jones
  • , David L. Paterson
  • , Iain B. Gosbell
  • *Corresponding author for this work

Research output: Contribution to journal › Letter › Research

Abstract

[Extract]
TO THE EDITOR—High vancomycin minimum inhibitory concentration (MIC) methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) have increasingly been associated with increased treatment failure and mortality [1, 2]. Recent MRSA treatment guidelines support the need for alternative antibiotic therapy in clinically failing patients, especially if the vancomycin MIC is 2 μg/mL or greater [3]. The current evidence suggests that vancomycin Etest is the method of choice for determining susceptibility [4]. However, because it is a nonautomated method, multiple laboratory issues arise. The ability to predict high vancomycin MIC episodes would circumvent some of these concerns. Therefore, we read with interest the prediction model proposed by Lubin and colleagues
Original languageEnglish
Pages (from-to)1166-1167
Number of pages2
JournalClinical Infectious Diseases
Volume53
Issue number11
DOIs
Publication statusPublished - 1 Dec 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Doubtful model utility in predicting high vancomycin minimum inhibitory concentration methicillin-resistant staphylococcus aureus bloodstream infection episodes'. Together they form a unique fingerprint.

Cite this